IMD International Medical Devices SpA (MIL:IMD) YoY EBITDA Growth: 4.65% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:IMD IMD International Medical Devices SpA MIL:IMD
44 GF Score
Price €1.31
GF Value €1.36
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is IMD International Medical Devices SpA YoY EBITDA Growth?

IMD International Medical Devices SpA MIL:IMD 44 YoY EBITDA Growth is 4.65% as of Dec. 2025. GuruFocus rates MIL:IMD with a GF Score™ of 44/100 and a GF Value™ of €1.36 (Fairly Valued). The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. IMD International Medical Devices SpA's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was 4.65%.

IMD International Medical Devices SpA's EBITDA per Share for the six months ended in Dec. 2025 was €0.09.

IMD International Medical Devices SpA YoY EBITDA Growth Related Terms

IMD International Medical Devices SpA YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for IMD International Medical Devices SpA's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMD International Medical Devices SpA YoY EBITDA Growth Chart

IMD International Medical Devices SpA Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
0.00 -29.10 -18.57 -9.60 -33.19

IMD International Medical Devices SpA Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial 0.00 12.00 -30.65 -56.43 4.65
MIL:IMD
44GF Score
IMD International Medical Devices SpA MIL:IMD
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IMD International Medical Devices SpA YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

IMD International Medical Devices SpA's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.151-0.226)/ | 0.226 |
=-33.19 %

IMD International Medical Devices SpA's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(0.09-0.086)/ | 0.086 |
=4.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 4.65% mean?
IMD International Medical Devices SpA (MIL:IMD) has a YoY EBITDA Growth of 4.65% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for IMD International Medical Devices SpA and its competitors.
Is IMD International Medical Devices SpA's YoY EBITDA Growth too high?
IMD International Medical Devices SpA's current YoY EBITDA Growth is 4.65%. Overall, IMD International Medical Devices SpA has a GF Score™ of 44/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IMD International Medical Devices SpA's YoY EBITDA Growth compare to ABT and SYK?
IMD International Medical Devices SpA's YoY EBITDA Growth of 4.65% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for IMD International Medical Devices SpA and its competitors. IMD International Medical Devices SpA's current YoY EBITDA Growth is 4.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMD International Medical Devices SpA stock overvalued right now?
Based on GuruFocus' analysis, IMD International Medical Devices SpA (MIL:IMD) is currently considered Fairly Valued. The stock's GF Value™ is €1.36, compared to a current price of €1.31 — trading 3.7% below its estimated fair value. The current YoY EBITDA Growth is 4.65%. IMD International Medical Devices SpA's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For IMD International Medical Devices SpA (MIL:IMD), the current YoY EBITDA Growth is 4.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IMD International Medical Devices SpA (MIL:IMD) Overvalued in 2026?

Based on GuruFocus' analysis, IMD International Medical Devices SpA stock appears to be undervalued. The current stock price of €1.31 is trading 3.7% below its estimated GF Value™ of €1.36. GuruFocus considers IMD International Medical Devices SpA to be Fairly Valued.

Key valuation signals for MIL:IMD:

  • YoY EBITDA Growth: 4.65%
  • GF Value™: €1.36 vs. price of €1.31 (3.7% below fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the MIL:IMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IMD International Medical Devices SpA Business Description

Address Via E. Fermi 26, Grassobbio, ITA, 24050
IMD International Medical Devices SpA is a company manufacturing X-ray medical equipment with a complete range of mobile imaging systems.
44GF Score

Get the complete analysis for MIL:IMD

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.31
Price
€1.36
GF Value